← Open Payments lookup

PAVEL MUDRENKO: Open Payments

NPI 1487402251 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$572 in 23 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $572

Food & beverage: $572
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation4$113
Merck Sharp & Dohme LLC4$98
Amgen Inc.3$80
AstraZeneca Pharmaceuticals LP2$43
Boston Scientific Corporation1$41
Novo Nordisk Inc2$36
Alnylam Pharmaceuticals Inc.1$34
United Therapeutics Corporation1$32
GlaxoSmithKline, LLC.1$23
Bayer Healthcare Pharmaceuticals Inc.1$19

Products named: LEQVIO, VERQUVO, Repatha, WATCHMAN FLX, AMVUTTRA, Tyvaso, SHINGRIX, WAINUA.

Industry payments across CA — which companies pay providers there.